Cargando…
Long-term benefits of high-intensity atorvastatin therapy in Chinese acute coronary syndrome patients undergoing percutaneous coronary intervention: A retrospective study
There is lack of long-term data on high-intensity statin therapy of Chinese acute coronary syndrome (ACS) patients scheduled to undergo percutaneous coronary intervention (PCI). In this retrospective study, we compared the long-term efficacy and safety of high-intensity and conventional atorvastatin...
Autores principales: | Liu, Hui, Dong, Aiqiao, Wang, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211933/ https://www.ncbi.nlm.nih.gov/pubmed/30334951 http://dx.doi.org/10.1097/MD.0000000000012687 |
Ejemplares similares
-
The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017) -
Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013) -
High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
por: He, Gui-Xin, et al.
Publicado: (2013) -
Short- and Long-term Outcomes in Patients with Connective Tissue Diseases Undergoing Percutaneous Coronary Intervention
por: Zhou, Li, et al.
Publicado: (2016) -
Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study
por: Choi, Ik Jun, et al.
Publicado: (2020)